SCHEMBL20118148

SCHEMBL20118148

CNC(=O)c1cc(Cc2ccc(NC)cc2)ccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.52
ADORA1 P30542 1/20 0.49
CSF1R P07333 2/20 0.45
TSHR P16473 1/20 0.44
KIT P10721 5/20 0.43
KDR P35968 3/20 0.43
PDGFRB P09619 1/20 0.43
FLT4 P35916 1/20 0.43
ILK Q13418 1/20 0.43
MAP3K20 Q9NYL2 1/20 0.43
MAPK14 Q16539 2/20 0.43
BRAF P15056 5/20 0.42
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
RAF1 P04049 2/20 0.42
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171414 0.85 LOXL2 (0.53) PARP1ADORA1CSF1RKDR
SCHEMBL14792981 0.85 PARP1 (0.52) PARP1ADORA1CSF1RTSHRKIT
SCHEMBL169192 0.84 KMT2A (0.54) PARP1CSF1RTSHRKDRMAPK14
SCHEMBL171424 0.82 PARP1 (0.49) PARP1ADORA1CSF1R
SCHEMBL246824 0.80 PARP1 (0.51) PARP1ADORA1CSF1RKITKDR
SCHEMBL30542691 0.80 PARP1 (0.51) PARP1ADORA1CSF1RKITKDR
SCHEMBL18922125 0.80 SMYD3 (0.58) PARP1ADORA1CSF1RKITKDR
SCHEMBL14566951 0.79 KDR (0.48) PARP1TSHRKDRMAP3K20MAPK14
SCHEMBL12020808 0.79 RAB9A (0.49) PARP1CSF1RALDH1A1GAAMAPT
SCHEMBL14009092 0.78 CCNC (0.56) PARP1CSF1RKITKDRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021016228-A1 COMBINATION THERAPY FOR TREATING RAS-MUTANT CANCERS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (US) 2021-01-28 WO disclosed
WO-2018081830-A9 COMBINATIONS OF AGENTS TO TREAT HEMATOLOGICAL MALIGNANCIES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2018-06-28 WO disclosed
WO-2018081830-A1 COMBINATIONS OF AGENTS TO TREAT HEMATOLOGICAL MALIGNANCIES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2018-05-03 WO disclosed